Search

Edwards Lifesciences Heart Valve Repair Patent Granted

USPTO granted patent US12605248B2 to Edwards Lifesciences Corporation on April 21, 2026. The patent covers valve repair systems and leaflet clip devices for reducing regurgitation through native heart valves, including a delivery apparatus and clipping member that transforms from a delivery configuration to an implantation configuration via tensioning members. The patent names Lauren R. Freschauf and Ralph Schneider as inventors.

European Patent - Clinical Event Evaluation - Edwards Lifesciences

The European Patent Office published European patent application EP4505472A1 for Edwards Lifesciences Corporation covering systems and methods for clinical event evaluation in health informatics. The patent includes IPC classifications G16H 10/20, G16H 50/70, G06F 40/20, G16H 15/00, and G16H 50/20, with designated states across EU member states and other European countries.

Edwards Lifesciences Percutaneous Mitral Valve Replacement Patent B2

The USPTO granted patent US12599480B2 to Edwards Lifesciences Corporation for a percutaneous mitral valve replacement device. The prosthetic heart valve includes an outer frame with atrial flange, an inner frame, and a valve structure with leaflets, designed to match the patient's native mitral valve anatomy. The patent contains 10 claims and was filed on November 15, 2023.

Edwards Lifesciences Valve Expansion Monitoring Patent Application

USPTO published patent application US20260096881A1 for Edwards Lifesciences Corporation on April 9, 2026. The application covers a prosthetic valve delivery apparatus with an indicator arm system configured to monitor valve expansion diameter at predetermined sizes. Medical device manufacturers developing cardiac valve delivery systems should monitor this publication for patent landscape implications.